This text investigates the molecular identification of tumor antigens and their specific roles in mediating immune responses within the context of clinical immunotherapy. Giorgio Parmiani, a recognized expert in tumor immunology, synthesizes decades of research to explain how the discovery of these antigens shifted the paradigm from non-specific cytokine therapy to targeted, antigen-based interventions. The book provides a rigorous framework for understanding how T cells and antibodies recognize malignant cells, offering a technical foundation for current clinical trials in solid tumors and hematological malignancies.

Experts in the field of oncology recognize this work as a foundational reference for understanding the transition toward targeted cancer immunotherapies. Researchers frequently cite the text for its detailed technical explanations of antigen processing and the clinical implications of immune cell interaction with malignant tissues.